LIPGENE: A truly integrated approach to tackling the metabolic syndrome

Nutrition Bulletin

Volumn 29, Issue 2, 2004, Pages 152-155

  Nugent, Anne ^a  

^a BRITISH NUTRITION FOUNDATION   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FAT; OMEGA 3 FATTY ACID; POLYUNSATURATED FATTY ACID;

CARDIOVASCULAR RISK; DIET THERAPY; DIETARY INTAKE; FAT INTAKE; FOOD COMPOSITION; GENE INTERACTION; GENETIC PREDISPOSITION; GENETIC VARIABILITY; HEALTH PROGRAM; HUMAN; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; NOTE; OBESITY; PREVALENCE; PRIORITY JOURNAL;

EID: 2942515143     PISSN: 01419684     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1467-3010.2004.00413.x     Document Type: Note

References (20)

1. BNF (British Nutrition Foundation) (1995) Briefing Paper: Trans Fatty Acids. British Nutrition Foundation, London.
2. BNF (British Nutrition Foundation) (1999) Briefing Paper: N-3 Fatty Acids and Health. British Nutrition Foundation, London.
3. Buttriss J (2003) Metabolic syndrome: new research underway. Nutrition Bulletin 28 (4): 381-5.
4. Din JN, Nessby DE & Flapan AD (2004) Omega 3 fatty acids and cardiovascular disease-fishing for a natural treatment. British Medical Journal 328: 30-5.
5. Espion-Montoro A, Lopez-Miranda J, Castro P et al. (1996) Monunsaturated fatty acid enriched diets lower plasma insulin levels and blood pressure in healthy young men. Nutrition Metabolism Cardiovascular Disease 6: 147-54.
6. Fasching P, Ratheiser K, Waldhausl W et al. (1991) Metabolic effects of fish oil supplementation in patients with impaired glucose tolerance. Diabetes 40: 583-9.
7. Gardner C & Kraemer H (1995) Monounsaturated versus polyunsaturated dietary fat and serum lipids: a meta-analysis. Arteriosclerosis, Thrombosis, and Vascular Biology 15: 1917-27.
8. Goldberg G (2003) Obesity FLAIR FLOW 4 Synthesis Report, Health Professionals no. 3. INRA, France.
9. Hercberg S, Preziosi P, Briancon S et al. (1998) A primary prevention trial using nutritional doses of antioxidant vitamins and minerals in cardiovascular diseases and cancers in a general population: the SU.VI.MAX study - design, methods, and participant characteristics. SUpplementation en VItamines et Mineraux AntioXydants. Control Clinical Trials 19 (4): 336-51.
10. Isomaa (2003) A major health hazard: the metabolic syndrome. Life Sciences 73: 2395-2411.
11. Knowler WC, Barrett-Connor E, Fowler SE et al. (2002) Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. New England Journal of Medicine 7: 393-403.
12. Lovejoy JC (1999) Dietary fatty acids and insulin resistance. Current Atherosclerosis Reports 1: 215-220.
13. Mann JI (2002) Diet and risk of coronary heart disease and type 2 diabetes. Lancet 360: 783-9.
14. Mokdad AH, Serdula MK, Dietz WH et al. (2000) The continuing epidemic of obesity in the Unites States. Journal of the American Medical Association 284: 1650-1.
15. van Ommen B & Stierum R (2002) Nutrigenomics: exploiting systems biology in the nutrition and health arena. Current Opinion in Biotechnology 13: 517-21.
16. Pomerleau J, Pudule I, Grinberga D et al. (2000) Patterns of body weight in the Baltic Republics. Public Health Nutrition 3: 3-10.
17. Roche HM (1999) Unsaturated fatty acids. Proceedings of the Nutrition Society 58: 397-401.
18. Vessby B (2003) Dietary fat, fatty acid composition in plasma and the metabolic syndrome. Current Opinion in Lipidology 14: 15-9.
19. World Bank Atlas Health and expenditure services (2000) Elderly Statistics in Europe. http://www.europa.eu.International/comm/eurostat.
20. Zimmer P, Alberti KG & Shaw J (2001) Global and societal implications of the diabetes epidemic. Nature 414: 782-7.